COMMUNIQUÉS West-GlobeNewswire

Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and China
27/02/2024
Tonix plans to File a Clinical Trial Notification (CTN) in Japan and Investigational New Drug (IND) application in China to support a registration-enabling Asian Phase 3 study without dosage adjustment based on U.S. [...]
Arcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
27/02/2024
Q4 net product revenues for ZORYVE® (roflumilast) cream 0.3% were $13.5 million, a 357% increase compared to the fourth quarter of 2022 and a 67% increase compared to the third quarter of 2023; driven by sequential [...]
Crossject obtains a financing up to €12 million, in two tranches
27/02/2024
Dijon, February 27, 2024 at 8:30am Crossject obtains a financing up to €12 million, in two tranches, from an entity managed by Heights Capital Management, in issued bonds convertible in new shares, with a conversion [...]
Crossject obtient un financement jusqu’à 12 millions d’euros en 2 tranches
27/02/2024
Dijon, le 27 février 2024 à 08h30 Crossject obtient un financement jusqu’à 12 millions d’euros en 2 tranches, auprès d’une entité gérée par Heights Capital Management, sous forme d’émission d’obligations convertibles en [...]
Mendus to participate in upcoming industry conferences
27/02/2024
Press release Stockholm, Sweden, February 27, 2024 Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it will participate in the [...]
NEXSTIM PLC’S FINANCIAL STATEMENTS BULLETIN 2023
27/02/2024
Company announcement, Helsinki 27 February 2024 at 9 am (EET) NEXSTIM PLC’S FINANCIAL STATEMENTS BULLETIN 2023 NEXSTIM CONTINUED TO GROW COMPARABLE NET SALES WITH A RECORD YEAR-END July–December 2023 The company’s net [...]
Zealand Pharma convenes its Annual General Meeting 2024
27/02/2024
Company Announcement – No. 10 / 2024 Zealand Pharma convenes its Annual General Meeting 2024 Notice to convene the Annual General Meeting of Zealand Pharma A/S (CVR no. 20 04 50 78) (the "Company"). The Board of [...]
Zealand Pharma Announces Financial Results for the Full Year 2023
27/02/2024
Company announcement - No. 9 / 2024 Zealand Pharma Announces Financial Results for the Full Year 2023 Significant progress delivered across our obesity and rare disease assets while building a solid financial position [...]
Alira Health publie le rapport mondial 2024 sur la fabrication sous contrat dans le secteur des technologies médicales
27/02/2024
En 2023, le marché mondial de l’externalisation des technologies médicales, dites medtech, a progressé de plus de 11 % pour atteindre 81,5 milliards de dollars, ce qui témoigne d’une forte résilience du marché [...]
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma
27/02/2024
Media Release COPENHAGEN, Denmark; February 27, 2024 FDA grants Priority Review with target action date of June 28, 2024 Application based on results from Phase 1/2 EPCORE™ NHL-1 trial demonstrating clinically [...]
Bitterroot Bio and Biotheus Announce Research Collaboration to Develop Bispecific Proteins in Cardio-Immunology
27/02/2024
Collaboration aims to discover novel bispecific proteins targeting immune modulators and inflammatory pathways implicated in cardiovascular disease PALO ALTO, Calif., and ZHUHAI, China, Feb. 26, 2024 (GLOBE NEWSWIRE [...]
RTG Medical Ranks #70 on Inc. 5000 Regionals List in the Midwest
27/02/2024
FREMONT, Neb., Feb. 26, 2024 (GLOBE NEWSWIRE) -- RTG Medical, a leading healthcare staffing agency, has been recognized as one of the top performers in the Midwest, securing the impressive #70 spot on the prestigious [...]
Ibogaine Treatment May Be More Effective During the Month of March, According to David Dardashti
26/02/2024
Miami, FL - Ibogaine by David Dardashti Suggests Theory Behind the Theory MIAMI, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Mental health advocate David Dardashti has suggested that the month of March may be the most effective [...]
Premier Health Reports 2024 First Quarter Results
26/02/2024
MONTRÉAL, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA ) (the “ Corporation ”), a leading Canadian Healthtech company, announces it has filed its Unaudited Quarterly Consolidated Financial [...]
Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement
26/02/2024
PALO ALTO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid [...]
Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference
26/02/2024
REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) [...]
Teladoc Health to Participate in Upcoming Investor Conference
26/02/2024
PURCHASE, NY, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that Mala Murthy, chief financial officer, will participate in the TD [...]
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
26/02/2024
PDUFA target action date for tovorafenib NDA in relapsed or progressive pLGG remains set for April 30, 2024 Phase 2 FIREFLY-1 tovorafenib registrational data published in Nature Medicine Ended 2023 with $366.3 million [...]
Travere Therapeutics to Present at Upcoming Investor Conferences
26/02/2024
SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the following upcoming investor conferences in March: Cowen 44 th Annual [...]

Pages